SXTP

60 Degrees Pharmaceuticals, Inc. Common Stock

1.04

USD

+0.03

+2.97%

Sep 22, 15:59 UTC -4

Closed

After-Market

1.06

+0.02

+2.40%

SXTP Earnings Reports

Positive Surprise Ratio

SXTP beat 2 of 12 last estimates.

17%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q2 26 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

60 Degrees Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Aug 14, 2026, SXTP reported earnings of -0.90 USD per share (EPS) for Q2 26, missing the estimate of -0.69 USD, resulting in a -29.76% surprise. Revenue reached 208.00 thousand, compared to an expected 188.70 thousand, with a 10.23% difference. The market reacted with a +1.27% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

PharmaCyte Biotech, Inc. Common Stock

Report Date

Sep 14, 2026 For Q1 27

Estimate

Actual

-$0.54

Surprise

Champions Oncology, Inc.

Report Date

Sep 10, 2026 For Q1 27

Estimate

-$0.01

Actual

-$0.03

Surprise

-194.12%

FAQ

What were 60 Degrees Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, 60 Degrees Pharmaceuticals, Inc. Common Stock reported EPS of -$0.90, missing estimates by -29.76%, and revenue of $208.00K, 10.23% above expectations.

How did the market react to 60 Degrees Pharmaceuticals, Inc. Common Stock's Q2 2026 earnings?

The stock price moved up 1.27%, changed from $1.18 before the earnings release to $1.20 the day after.

When is 60 Degrees Pharmaceuticals, Inc. Common Stock expected to report next?

The next earning report is scheduled for --.

What are the forecasts for 60 Degrees Pharmaceuticals, Inc. Common Stock's next earnings report?

Based on -- analysts, 60 Degrees Pharmaceuticals, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.